ROSEN Firm Encourages uniQure Investors to Secure Counsel

Investors advised to seek legal representation amid concerns over company's practices.

Mar. 29, 2026 at 4:38am

Got story updates? Submit your updates here. ›

The ROSEN Law Firm, a global investor rights law practice, is encouraging investors in uniQure N.V., a biotechnology company, to seek legal counsel to protect their interests. The firm believes uniQure may have engaged in practices that could negatively impact investors, prompting the recommendation for affected parties to secure representation.

Why it matters

As a leading investor rights firm, ROSEN's decision to issue this public encouragement suggests there may be significant concerns over uniQure's conduct that could expose investors to financial harm. This highlights the importance for investors to stay vigilant and seek professional guidance when faced with potential corporate wrongdoing.

The details

The ROSEN Law Firm specializes in representing investors in securities fraud cases. In this instance, the firm believes uniQure may have engaged in actions that could negatively impact its shareholders, though the specific details of the firm's concerns have not been publicly disclosed.

  • The ROSEN Law Firm issued its recommendation on March 28, 2026.

The players

ROSEN Law Firm

A global investor rights law practice that specializes in representing investors in securities fraud cases.

uniQure N.V.

A biotechnology company that develops gene therapies for rare and other devastating diseases.

Got photos? Submit your photos here. ›

The takeaway

This announcement from the ROSEN Law Firm serves as a reminder for investors to remain vigilant and seek professional guidance when faced with potential corporate misconduct that could impact their financial interests.